Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study
Bin Jia,1,* Hui Lv,2,* Ting Gong,2 Xin Wang,2 Qing Ma,2 Yaoyao Ren,2 Linlin Zhang,2 Diansheng Zhong2 1Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cance...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2025-11-01
|
| Cyfres: | Vascular Health and Risk Management |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.dovepress.com/evaluating-rivaroxaban-for-thromboprophylaxis-in-cancer-patients-with--peer-reviewed-fulltext-article-VHRM |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
